
AP23846
CAS No. 878654-51-4
AP23846 ( —— )
产品货号. M36255 CAS No. 878654-51-4
AP23846 is a novel and potent Src family kinase inhibitor that reduces vascular endothelial growth factor and interleukin-8 expression and abrogates downstream angiogenic processes in human solid tumor cell lines.
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
2MG | ¥3786 | 有现货 |
![]() ![]() |
5MG | ¥5830 | 有现货 |
![]() ![]() |
10MG | ¥7970 | 有现货 |
![]() ![]() |
25MG | ¥11886 | 有现货 |
![]() ![]() |
50MG | ¥15484 | 有现货 |
![]() ![]() |
100MG | ¥19125 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称AP23846
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述AP23846 is a novel and potent Src family kinase inhibitor that reduces vascular endothelial growth factor and interleukin-8 expression and abrogates downstream angiogenic processes in human solid tumor cell lines.
-
产品描述AP23846 is a novel and potent Src family kinase inhibitor that reduces vascular endothelial growth factor and interleukin-8 expression and abrogates downstream angiogenic processes in human solid tumor cell lines.
-
体外实验——
-
体内实验——
-
同义词——
-
通路Angiogenesis
-
靶点Src
-
受体Src
-
研究领域——
-
适应症——
化学信息
-
CAS Number878654-51-4
-
分子量439.53
-
分子式C24H34N5OP
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESO=P(C1=CC=C(C=C1)NC2=NC(=NC3=C2N=CN3CC)C4CCCC4)(CCC)CCC
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
产品手册




关联产品
-
AP23846
AP23846 is a novel and potent Src family kinase inhibitor that reduces vascular endothelial growth factor and interleukin-8 expression and abrogates downstream angiogenic processes in human solid tumor cell lines.
-
AD57
AD57 是一种具有口服活性的多种激酶抑制剂,抑制 RET、BRAF、S6K 和 Src 活性,但对 mTOR 的活性明显减弱。
-
WAY-303290
WAY-303290 抑制酪氨酸激酶 p56lck SH2 结构域的 pY 结合位点。